SEC Rule 15c3-3 amendments will most likely be delayed due to COVID-19 disruption
28 April 2020 New York
Image: ImageFlow/Shutterstock.com
In the US, amendments to SEC Rule 15c3-3, which effects when equities can be posted as collateral, were rumoured to be scheduled for sign-off this year after a sustained lobbying effort, but the COVID-19 pandemic may now scupper those plans at the final hurdle.
Currently, the interpretation of this rule is the largest block to unlocking a tremendous amount of liquidity and supply in the US, as it limits the collateral type posted by borrowers to cash, US treasuries and US agency debt.
It also means that many beneficial owners are unable to meet the growing demand from borrowers to engage in non-cash transactions.
Speaking to SLT in January, Scot Warren, COO at the Chicago-based Options Clearing Corporation, said: “For the broker-dealer community, it’s critically important to effectively manage their assets and regulatory capital requirements. Changing 15c3-3 so that borrowers can post equities as collateral would enable broker-dealers to free up more liquid assets and utilise their inventory of equities to collateralise their borrows.”
The effort to make the much-sought-after changes have been led by the Risk Management Association (RMA) and the Securities Industry and Financial Markets Association and at the RMA’s annual event in October 2019, the common view was that progress was being made.
Christopher Kunkle, head of agency lending and managing director at BMO and senior figure within the RMA, tells SLT: “In the US, we are proactively working towards equities as collateral in securities finance transactions.”
However, he now predicts these plans will have been thrown off-track in the same way many other regulatory timetables have been, as market overseers grapple with maintaining business as normal practices under pandemic-induced lockdown conditions.
The SEC has gone into a “high priority item” methodology within the COVID-19 pandemic, he explains, so 15c3-3 will “probably not be reviewed during this timeframe”.
The spread of the coronavirus has already caused delays to the first phase of the Securities Financing Transactions Regulation (SFTR) and Basel III, and is still considered a threat to many other go-live dates across global markets.
Further delays will be a blow to those engaged in the lobbying effort and industry stakeholders that have enviously looked at the European regulatory landscape, which has allowed equities to become a much more common form of collateral used.
SLT’s full conversation with Christopher Kunkle, where he also evaluates the effectiveness of the Federal Reserve’s efforts to maintain liquidity during last month’s market turbulence, appeared in the latest issue of Securities Lending Times.
Currently, the interpretation of this rule is the largest block to unlocking a tremendous amount of liquidity and supply in the US, as it limits the collateral type posted by borrowers to cash, US treasuries and US agency debt.
It also means that many beneficial owners are unable to meet the growing demand from borrowers to engage in non-cash transactions.
Speaking to SLT in January, Scot Warren, COO at the Chicago-based Options Clearing Corporation, said: “For the broker-dealer community, it’s critically important to effectively manage their assets and regulatory capital requirements. Changing 15c3-3 so that borrowers can post equities as collateral would enable broker-dealers to free up more liquid assets and utilise their inventory of equities to collateralise their borrows.”
The effort to make the much-sought-after changes have been led by the Risk Management Association (RMA) and the Securities Industry and Financial Markets Association and at the RMA’s annual event in October 2019, the common view was that progress was being made.
Christopher Kunkle, head of agency lending and managing director at BMO and senior figure within the RMA, tells SLT: “In the US, we are proactively working towards equities as collateral in securities finance transactions.”
However, he now predicts these plans will have been thrown off-track in the same way many other regulatory timetables have been, as market overseers grapple with maintaining business as normal practices under pandemic-induced lockdown conditions.
The SEC has gone into a “high priority item” methodology within the COVID-19 pandemic, he explains, so 15c3-3 will “probably not be reviewed during this timeframe”.
The spread of the coronavirus has already caused delays to the first phase of the Securities Financing Transactions Regulation (SFTR) and Basel III, and is still considered a threat to many other go-live dates across global markets.
Further delays will be a blow to those engaged in the lobbying effort and industry stakeholders that have enviously looked at the European regulatory landscape, which has allowed equities to become a much more common form of collateral used.
SLT’s full conversation with Christopher Kunkle, where he also evaluates the effectiveness of the Federal Reserve’s efforts to maintain liquidity during last month’s market turbulence, appeared in the latest issue of Securities Lending Times.
← Previous regulation article
AcadiaSoft partners with Margin Reform & Margin Tonic to support UMR compliance
AcadiaSoft partners with Margin Reform & Margin Tonic to support UMR compliance
NO FEE, NO RISK
100% ON RETURNS If you invest in only one securities finance news source this year, make sure it is your free subscription to Securities Finance Times
100% ON RETURNS If you invest in only one securities finance news source this year, make sure it is your free subscription to Securities Finance Times
